Persistent viral RNA shedding after COVID-19 symptom resolution in older convalescent plasma donors

Viral Infections, Non-HIV

Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19

J Med Virol.

Li TZ, Cao ZH, Chen Y, Cai MT, Zhang LY, Xu H, Zhang JY, Ma CH, Liu Y, Gao LJ, Duan ZH, Mou DL, Liang LC

doi: 10.1002/jmv.26280.

Viral Infections, Non-HIV

Improved Clinical Symptoms and Mortality on Severe/Critical COVID-19 Patients Utilizing Convalescent Plasma Transfusion

Blood.

Xia X, Li K, Wu L, Wang Z, Zhu M, Huang B, Li J, Wang Z, Wu W, Wu M, Li W, Li L, Cai Y, Bosco B, Zhong A, Liu X, Lv T, Gan Z, Chen G, Pan Y, Liu C, Zhang K, Xu X, Wang C, Wang Q

doi: 10.1182/blood.2020007079.

Viral Infections, Non-HIV

Convalescent plasma transfusion for the treatment of COVID-19: Systematic review

J Med Virol.

Rajendran K, Krishnasamy N, Rangarajan J, Rathinam J, Natarajan M, Ramachandran A

doi: 10.1002/jmv.25961.

Sepsis

Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

Crit Care

Bermejo-Martin JF, González-Rivera M, Almansa R, Micheloud D, Tedim AP, Domínguez-Gil M, Resino S, Martín-Fernández M, Ryan Murua P, Pérez-García F, Tamayo L, Lopez-Izquierdo R, Bustamante E, Aldecoa C, Gómez JM, Rico-Feijoo J, Orduña A, Méndez R, Fernández Natal I, Megías G, González-Estecha M, Carriedo D, Doncel C, Jorge N, Ortega A, de la Fuente A, Del Campo F, Fernández-Ratero JA, Trapiello W, González-Jiménez P, Ruiz G, Kelvin AA, Ostadgavahi AT, Oneizat R, Ruiz LM, Miguéns I, Gargallo E, Muñoz I, Pelegrin S, Martín S, García Olivares P, Cedeño JA, Ruiz Albi T, Puertas C, Berezo JÁ, Renedo G, Herrán R, Bustamante-Munguira J, Enríquez P, Cicuendez R, Blanco J, Abadia J, Gómez Barquero J, Mamolar N, Blanca-López N, Valdivia LJ, Fernández Caso B, Mantecón MÁ, Motos A, Fernandez-Barat L, Ferrer R, Barbé F, Torres A, Menéndez R, Eiros JM, Kelvin DJ

doi: 10.1186/s13054-020-03398-0

Viral Infections, Non-HIV

Clearance and Persistence of SARS-CoV-2 RNA in COVID-19 patients

J Med Virol.

Carmo A, Pereira-Vaz J, Mota V, Mendes A, Morais C, da Silva AC, Camilo E, Pinto CS, Cunha E, Pereira J, Coucelo M, Martinho P, Correia L, Marques G, Araújo L, Rodrigues F

doi: 10.1002/jmv.26103.

Viral Infections, Non-HIV

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

N Engl J Med

Libster R, Pérez Marc G, Wappner D, Coviello S, Bianchi A, Braem V, Esteban I, Caballero MT, Wood C, Berrueta M, Rondan A, Lescano G, Cruz P, Ritou Y, Fernández Viña V, Álvarez Paggi D, Esperante S, Ferreti A, Ofman G, Ciganda Á, Rodriguez R, Lantos J, Valentini R, Itcovici N, Hintze A, Oyarvide ML, Etchegaray C, Neira A, Name I, Alfonso J, López Castelo R, Caruso G, Rapelius S, Alvez F, Etchenique F, Dimase F, Alvarez D, Aranda SS, Sánchez Yanotti C, De Luca J, Jares Baglivo S, Laudanno S, Nowogrodzki F, Larrea R, Silveyra M, Leberzstein G, Debonis A, Molinos J, González M, Perez E, Kreplak N, Pastor Argüello S, Gibbons L, Althabe F, Bergel E, Polack FP, Fundación INFANT–COVID-19 Group.

doi: 10.1056/NEJMoa2033700

Viral Infections, Non-HIV

Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy

Int J Infect Dis.

Sun M, Xu Y, He H, Zhang L, Wang X, Qiu Q, Sun C, Guo Y, Qiu S, Ma K

doi: 10.1016/j.ijid.2020.06.107.

Viral Infections, Non-HIV

The duration of viral shedding of discharged patients with severe COVID-19

Clin Infect Dis.

Zhou B, She J, Wang Y, Ma X

doi: 10.1093/cid/ciaa451.

Further Publications Infectiology

Plasma from post-COVID-19 and COVID-19-Vaccinated Donors Results in Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins

J Infect Dis

Karbiener M, Farcet MR, Schwaiger J, Powers N, Lenart J, Stewart JM, Tallman H, Kreil TR

doi: 10.1093/infdis/jiab482

Related content

Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19

Improved Clinical Symptoms and Mortality on Severe/Critical COVID-19 Patients Utilizing Convalescent Plasma Transfusion

Convalescent plasma transfusion for the treatment of COVID-19: Systematic review

Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

Clearance and Persistence of SARS-CoV-2 RNA in COVID-19 patients

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy

The duration of viral shedding of discharged patients with severe COVID-19

Plasma from post-COVID-19 and COVID-19-Vaccinated Donors Results in Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins